Latest:
Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress
Experts from across oncology specialties discuss the abstracts and presentations they are most looking forward to seeing at the 2024 ESMO Congress.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
David T. Marshall, MD
Latest:
Dr. Marshall on ASCENDE-RT Trial for Prostate Cancer
David T. Marshall, MD, MS, professor, director, Medical Residency Program, Department of Radiation Oncology, Medical University of South Carolina, discusses the ASCENDE-RT trial, which compared dose-escalated external beam radiation therapy versus low-dose-rate brachytherapy for men with unfavorable-risk localized prostate cancer.
Dawn Hershman, MD, MS
Latest:
Dr. Hershman on the Use of Endocrine Therapy in Premenopausal HR+/HER2- Breast Cancer
Dawn Hershman, MD, MS, professor of medicine and epidemiology, leader of the Breast Cancer Program of the Herbert Irving Comprehensive Cancer Center at Columbia University, discusses the use of endocrine therapy in premenopausal women with early-stage hormone receptor (HR)–positive, HER2-negative breast cancer.
Dawn L. Hershman, MD
Latest:
Dr. Hershman on Late Effects of Intermittent ADT for Prostate Cancer Patients
Dawn Hershman, MD, Associate Professor Medicine at Columbia University Medical Center, discusses the late-effects of intermittent androgen deprivation therapy (ADT) to continuous ADT in prostate cancer.
Dean F. Bajorin, MD, MSKCC
Latest:
Making an Impact in the Fight Against GU Cancers as Scientist, Physician, and Teacher
Long before Dean F. Bajorin, MD, would travel the world as a renowned expert in genitourinary cancers—presenting at international conferences, working with major task forces, and changing the paradigms of care for patients in every corner of the globe—he began with a decidedly shorter journey: to college.
Deanna J. Attai, MD
Latest:
Dr. Attai on the Challenges With Implementing Survivorship Care Plans
Deanna J. Attai, MD, assistant clinical professor of surgery at the David Geffen School of Medicine at the University of California Los Angeles (UCLA), breast surgeon at UCLA Health, discusses studies exploring the challenges with survivorship care plan implementation for patients with cancer in an interview during the 2017 ASCO Annual Meeting.
Deborah A. Bradley, MD
Latest:
Dr. Bradley on Adverse Events Associated With Enzalutamide and Apalutamide in Prostate Cancer
Deborah A. Bradley, MD, medical oncologist, Levine Cancer Institute, Atrium Health, discusses the adverse events (AEs) that are associated with enzalutamide (Xtandi) and apalutamide (Erleada) in prostate cancer.
Deborah Abrams Kaplan
Latest:
Addressing AYA Cancer Requires a Tailored Approach to Practice
Investigators have expanded the scientific understanding of cancer in the adolescent young adult patient population over the past decade. However, unmet needs remain in establishing treatment standards, addressing unique survivorship challenges, and providing a framework for patients to reference as they navigate their cancer journey.
Deborah Krakow, MD
Latest:
Dr. Krakow on Genetic Testing in Ovarian Cancer
Deborah Krakow, MD, professor and chair, Department of Obstetrics and Gynecology, professor of Orthopaedic Surgery and Human Genetics, University of California, Los Angeles, discusses genetic testing in patients with ovarian cancer.